Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02783430

Organisation Name: University Hospital, Lille

Overal Status: Recruiting

Start Date: September 8, 2016

Last Update: December 11, 2018

Lead Sponsor: University Hospital, Lille

Brief Summary: KetaPal is a placebo-controlled randomized trial designed to demonstrate the antidepressant action of ketamine in palliative care situations. Half of participants will receive Ketamine and Milnacipran in combination, while the other half will receive a Placebo and Milnacipran in combination.

Conditions:
  • Depression


Total execution time in seconds: 0.2204852104187